中国—上海合作组织代谢性疾病合作中心在沪揭牌—— 打造服务上合组织各国人民健康的民生工程
Ren Min Ri Bao·2026-02-27 23:15

Core Viewpoint - The establishment of the China-SCO Metabolic Disease Cooperation Center in Shanghai represents a forward-looking initiative aimed at enhancing healthcare accessibility and treatment efficiency among SCO member states, leveraging advancements in digital and telemedicine technologies [1][2]. Group 1: Establishment and Significance - The China-SCO Metabolic Disease Cooperation Center was inaugurated on February 27, with representatives from over 20 countries in attendance, highlighting the collaborative effort to address metabolic diseases [1]. - The center's establishment aligns with the aspirations of member countries for improved healthcare and reflects China's commitment to building a community of shared health and well-being within the SCO framework [2][7]. Group 2: Health Challenges and Regional Impact - Metabolic diseases such as diabetes and obesity pose significant public health threats, affecting quality of life and placing immense pressure on healthcare systems across SCO member states, which collectively cover approximately 34 billion people [1]. - Data indicates that one in two metabolic disease patients globally comes from SCO-related countries, with over 70% of deaths linked to these diseases, marking them as the leading cause of non-communicable diseases in the region [1]. Group 3: Collaborative Efforts and Knowledge Sharing - The center aims to create a specialized platform for the prevention and treatment of metabolic diseases, fostering cooperation and resource sharing among member countries to address regional health needs [2][3]. - Various countries within the SCO have developed unique strategies for managing metabolic diseases, showcasing a wealth of local experience that can be shared to create an inclusive and effective governance system [3][4]. Group 4: China's Health Management Model - The China-SCO Metabolic Disease Cooperation Center will undertake tasks such as medical assistance, training, and technology transfer, with plans to train 2,000 experts and share 500 medical technologies within three years [7]. - The successful implementation of China's "prevention, screening, diagnosis, treatment, and management" health management system has led to significant improvements in patient outcomes, with a notable increase in the comprehensive compliance rate of metabolic indicators from 7% to 21% over the past decade [6][7].

中国—上海合作组织代谢性疾病合作中心在沪揭牌—— 打造服务上合组织各国人民健康的民生工程 - Reportify